Media is loading
Overall Goals and Objectives:
1. To understand testing strategies for rare genetic diseases.
2. To understand the pathogenesis of lung and liver diseases in Alpha-1 Antitrypsin deficiency.
3. To understand the impact of rare disease communities in the health care system.
Strange, Charlie, "Rare Diseases: The Case of Alpha-1 Antitrypsin Deficiency" (2011). Division of Pulmonary and Critical Care Medicine Presentations and Grand Rounds. Presentation 27.
Dr. Strange is a Professor of Pulmonary, Critical Care, Allergy and Sleep Medicine at MUSC. Dr. Strange's recent honors are as follows: Best Doctors in America, 2003-2012: General Pulmonary and Critical Care Medicine, Interstitial Lung Diseases, Chronic Obstructive Pulmonary Disease, America's Top Physicians 2004-2010, Consumers Research Council of America, Who's Who in Medicine and Healthcare 2006-9, First Runner-up, Medical Jeopardy, AOA Chapter, 1999; Second Runner-Up 2008. MUSC Medical Student Faculty Excellence Award nominee-2006, Distinguished Service Award 2007-Chest Foundation Community Service Award 2008-Alpha-1 Association. Dr. Strange's major interests are Alpha-1 Antitrypsin, Deficiency Chronic Obstructive Pulmonary Disease, Scleroderma and Interstitial Lung Disease, and Pulmonary Hypertension.